1. Home
  2. PSBD vs LXRX Comparison

PSBD vs LXRX Comparison

Compare PSBD & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSBD
  • LXRX
  • Stock Information
  • Founded
  • PSBD 2009
  • LXRX 1995
  • Country
  • PSBD United States
  • LXRX United States
  • Employees
  • PSBD N/A
  • LXRX N/A
  • Industry
  • PSBD
  • LXRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PSBD
  • LXRX Health Care
  • Exchange
  • PSBD Nasdaq
  • LXRX Nasdaq
  • Market Cap
  • PSBD 428.2M
  • LXRX 428.8M
  • IPO Year
  • PSBD 2024
  • LXRX 2000
  • Fundamental
  • Price
  • PSBD $12.95
  • LXRX $1.55
  • Analyst Decision
  • PSBD Hold
  • LXRX Buy
  • Analyst Count
  • PSBD 4
  • LXRX 5
  • Target Price
  • PSBD $13.88
  • LXRX $3.23
  • AVG Volume (30 Days)
  • PSBD 73.2K
  • LXRX 2.5M
  • Earning Date
  • PSBD 11-04-2025
  • LXRX 11-11-2025
  • Dividend Yield
  • PSBD 13.96%
  • LXRX N/A
  • EPS Growth
  • PSBD N/A
  • LXRX N/A
  • EPS
  • PSBD N/A
  • LXRX N/A
  • Revenue
  • PSBD N/A
  • LXRX $58,432,000.00
  • Revenue This Year
  • PSBD N/A
  • LXRX $67.21
  • Revenue Next Year
  • PSBD N/A
  • LXRX N/A
  • P/E Ratio
  • PSBD N/A
  • LXRX N/A
  • Revenue Growth
  • PSBD N/A
  • LXRX 1504.83
  • 52 Week Low
  • PSBD $11.51
  • LXRX $0.28
  • 52 Week High
  • PSBD $16.32
  • LXRX $2.18
  • Technical
  • Relative Strength Index (RSI)
  • PSBD 47.29
  • LXRX 73.01
  • Support Level
  • PSBD $12.07
  • LXRX $1.28
  • Resistance Level
  • PSBD $12.59
  • LXRX $1.42
  • Average True Range (ATR)
  • PSBD 0.39
  • LXRX 0.09
  • MACD
  • PSBD -0.04
  • LXRX 0.03
  • Stochastic Oscillator
  • PSBD 50.25
  • LXRX 100.00

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

About LXRX Lexicon Pharmaceuticals Inc.

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Share on Social Networks: